Tag: AMTAGVI therapy

Home / AMTAGVI therapy

Categories

Lifileucel is approved by the USFDA for unresectable or metastatic melanoma

The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or met...
amtagvi-therapy

Scan the code